News
Sanofi said it agreed to buy U.K. vaccine developer Vicebio for up to $1.6 billion, adding vaccine candidates for respiratory syncytial virus and human metapneumovirus to its pipeline.
Indian equity benchmarks, the BSE Sensex and NSE Nifty, are set to open higher on Tuesday, supported by overnight gains on ...
Indian markets may open higher as GIFT Nifty rises and key sectors show momentum. Track live updates and market cues now!
Strong gains in banking heavyweights such as HDFC Bank and ICICI Bank helped Indian market benchmarks rebound on Monday, 21 ...
Specifically, the Clinton-appointed judge ruled that Trump’s Office of Management and Budget broke the law by taking down the ...
The S&P/TSX Composite Index is up 2.99 points or 0.01% today to 27317.00 --Off 0.26% from its record close of 27386.93 hit Thursday, July 17, 2025 --Up 8.97% from the Inauguration Day close of ...
In the span of about a week, Opendoor Technologies Inc. has gone from a struggling former pandemic-era darling to the talk of ...
Live Updates Live Coverage Updates appear automatically as they are published. Stocks Drop Near the End of Trading 4:10 pm ...
UY Scuti Acquisition said it and Isdera Group have agreed to merge. Under the terms of the agreement, UYSC will merge with and into its subsidiary, Isdera, which would become the company listed on ...
S&P 500 posts first close above 6,300, Nasdaq hits a record ahead of big tech earnings: Live updates
U.S. stocks moved higher on Monday as optimism around earnings overshadowed any investor fears over the latest developments ...
The president filed a lawsuit in Miami court Friday against Dow Jones, News Corp, Rupert Murdoch, and two Wall Street Journal ...
iTeos Therapeutics has agreed to be acquired by privately held Concentra Biosciences in a deal initially worth roughly $385 million. iTeos on Monday said Concentra will pay nearly $10.05 a share in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results